BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 1, 2025
See today's BioWorld
Home
» Other news to note for Jan. 18, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Jan. 18, 2022
Jan. 18, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Almirall, Amagma, Artizan, Bayer, Betterlife, Celmatix, Claritas, Cosette, Cybin, Cytoimmune, Daiichi Sankyo, Endo, Endosane, Eracal, Evelo, Evgen, Evotec, Feldan, Filament, Immuron, Innovent, IRB Barcelona, J&J, Kyowa Kirin, Lantern, Lava, Leyden, Merck & Co., Mindrank, Neurimmune, Novo Nordisk, Nrx, Ono, Poolbeg, Praxis, Ridgeback, Qualigen, Vanda, Virpax, Wesana.
BioWorld
Briefs
Other news to note
Coronavirus